iSERA Lifesciences Ltd

BSE: 534920

total announcements

534920.BO · 15 min delayed

BSECompany Update2 Sept 2026

iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) has filed with the exchange copy of newspaper publication.

iSERA Lifesciences Ltd has filed a newspaper publication with the BSE regarding its 34th Annual General Meeting to be held on September 29, 2026, through video conferencing.

Read more →📎 1 attachment

BSEOthersResults1 Sept 2026

iSERA Lifesciences Ltd

We hereby informed that Board of Directors of the Company at its meeting held on Tuesday, the 01st September, 2026 discuss the agenda attached herewith.

iSERA Lifesciences Ltd has informed about the outcome of its Board Meeting held on September 1, 2026, where the Board approved the notice for the 34th Annual General Meeting, audited standalone financial statements for FY 2025-26, and the Annual Report for FY 2025-26.

Read more →📎 1 attachment

BSECompany UpdateResults14 Aug 2026

iSERA Lifesciences Ltd

We hereby submit the monitoring Agency Report for utilization of proceeds of Rights Issue of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the quarter ended ....

iSERA Lifesciences Ltd has submitted a monitoring agency report for the utilization of proceeds of its rights issue for the quarter ended June 30, 2026, indicating no deviation from the objects of the issue.

Read more →📎 1 attachment

BSEResultResults7 Aug 2026

iSERA Lifesciences Ltd

We are hereby submitting the Unaudited Financial Results of the Company for the quarter ended June 30, 2026.

iSERA Lifesciences Ltd has submitted its unaudited financial results for the quarter ended June 30, 2026, showing a profit of Rs. 52.58 lakhs, with revenue from operations at Rs. 11,618 lakhs and total expenses at Rs. 33.62 lakhs.

Read more →📎 1 attachment

BSEBoard MeetingResults7 Aug 2026

iSERA Lifesciences Ltd

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the Board of Directors of the Company at its meeting held on ....

iSERA Lifesciences Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 11,618 lakhs and net profit at Rs. 5,208 lakhs.

Read more →📎 1 attachment

BSEBoard MeetingResults3 Aug 2026

iSERA Lifesciences Ltd

Isera Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....

iSERA Lifesciences Ltd has scheduled a Board Meeting on 07/08/2026 to consider and approve the unaudited financial results for the quarter ended 30/06/2026.

Read more →📎 1 attachment